Dynacaz Mr 30 mg, 60 mg, 90 mg MR tablets.
PDF Leaflet Revision Date: 14 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
For Type 2 diabetes management when diet and exercise are insufficient.
Dosage (summary)
Initial: 30 mg once daily with breakfast; max: 120 mg/day.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Safety not established in pregnancy or lactation.
Key Drug Interactions
- Miconazole
- Alcohol
- Fluoroquinolones
Contraindications
- Hypersensitivity to gliclazide
- Type 1 diabetes
- Severe renal or hepatic insufficiency
Common side effects
- Hypoglycaemia
- Headache
- Dizziness
- Gastrointestinal disturbances
Counselling Points
- Take with breakfast
- Monitor blood glucose regularly
- Avoid skipping meals
Serious warnings
- Risk of cardiovascular mortality
- Severe hypoglycaemia possible
Important Disclaimer
The Dynacaz Mr 30 mg, 60 mg, 90 mg MR tablets. professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
